Location History:
- Pohang, KR (2006 - 2010)
- Daejeon, KR (2010 - 2024)
Company Filing History:
8 out of 2,613 
5 out of 10 
4 out of 87 
Years Active: 2006-2025
Title: **Innovative Contributions of Inventor Gou Young Koh**
Introduction
Gou Young Koh is a distinguished inventor based in Daejeon, South Korea. With an impressive portfolio of 14 patents, he has made significant strides in the field of medical biotechnology, particularly concerning angiogenic diseases. His pioneering inventions demonstrate a commitment to advancing healthcare solutions through innovative antibody therapies.
Latest Patents
Among his latest patents, one notable invention is directed towards an antibody that binds to Tie2 and its related components. This invention addresses the need for a therapeutic composition aimed at preventing or treating angiogenic diseases. It encompasses an antibody or antigen-binding fragment, the nucleic acid encoding it, and a manufacturing method, providing a comprehensive approach to tackling complex medical conditions.
Another significant patent involves the development of anti-angiopoietin-2 (Ang2) antibodies that induce Tie2 activation. These mouse antibodies not only bind to Ang2 but also hold the dual functionality of activating the Tie2 receptor while neutralizing Ang2. The therapeutic implications of these anti-Ang2 antibodies are profound, as they possess the capability to normalize abnormal and pathological blood vessels, offering hope for various diseases associated with vascular abnormalities.
Career Highlights
Gou Young Koh has been associated with prominent institutions, including the Korea Advanced Institute of Science and Technology and Aprogen Inc. His work in these organizations has significantly contributed to the advancement of biopharmaceutical innovations, solidifying his reputation as a leading inventor in the biotechnology sector.
Collaborations
Throughout his career, Gou Young Koh has collaborated with several esteemed colleagues, including Chung-Hyun Cho and Jaeryung Kim. These collaborations have fostered an enriched environment for innovation and research, leading to the development of groundbreaking therapeutic solutions.
Conclusion
Gou Young Koh's impressive patent portfolio and his commitment to research in angiogenic diseases showcase the vital role of inventors in pushing the boundaries of medical science. His work continues to inspire future innovations, reaffirming the importance of collaborative efforts in the pursuit of transformative health solutions.